214  Total SME IPOs listed in 2025

9,804.70 Crs.  Total funds raised in 2025

145  SME IPOs listed with Gain in 2025

69  SME IPOs listed with loss in 2025

214  Total SME IPOs listed in 2025

9,804.70 Crs.  Total funds raised in 2025

145  SME IPOs listed with Gain in 2025

69  SME IPOs listed with loss in 2025

214  Total SME IPOs listed in 2025

9,804.70 Crs.  Total funds raised in 2025

145  SME IPOs listed with Gain in 2025

69  SME IPOs listed with loss in 2025

214  Total SME IPOs listed in 2025

9804.70 Crs.  Total funds raised in 2,025.00

145  SME IPOs listed with Gain in 2025

69  SME IPOs listed with loss in 2025

Aptus Pharma IPO (Aptus Pharma Limited IPO) Detail

Aptus Pharma Limited is an Pharmaceutical based company, located in Ahmedabad, Aptus Pharma Limited IPO size was 13.02 Cr. and was issued at 70.00 per share. The share of Aptus Pharma Limited were listed at 80.80 per share and are currently trading at 88.32 per share.

Type :
Sub Sector : Marketing, And Distribution Of Finished Pharmaceutical Formulations
SME IPO
BSE SME

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
24.55 Cr.

PAT :
3.09 Cr.

Pricing Report

Issue Price :
70.00

Listing Price :
80.80

Current Market Price :
88.32

Issue Price vs CMP :
18.32 (26.17%)

listing Price vs CMP :
7.52 (9.31%)

Performance Report (CAGR* wise)

CAGR : 1243069.28
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.

About Aptus Pharma

Company Information
Aptus Pharma is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model. They do not own any manufacturing plants but has entered into contract manufacturing agreement with seven manufacturing units. under various arrangements. Of these, they have formal loan and license agreements in place with two manufacturing units. The remaining production is carried out through informal arrangements with Other manufacturers, based on purchase orders (PO). They provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipidlowering, and general wellness products. These are offered across a variety of dosage forms,
Show More
Object of Issue
  • [{"particulars":"Capital Expenditure for Office Premises with furniture and Industrial Racks","amount":"1"},{"particulars":"Working Capital","amount":"8"},{"particulars":"General corporate purposes","amount":null}]

Aptus Pharma SME IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Sep, 2025
IPO Size :
13.02 Cr.
Market Cap :
48.02 Cr.   
IPO Subscription :
22.27 X     
PE Multiple :
15.49
Anchor Investors:
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

See Other SME IPOs in Ahmedabad

DSM Fresh Foods Limited

  Fresh meat and ready-to-cook/eat non-veg products retailer

  New Delhi


Shlokka Dyes Limited

  Manufacturing of reactive dyes and pigments

  Bharuch


Greenleaf Envirotech Limited

  Providing engineering, procurement, construction (EPC) and turnkey solutions for Wastewater Treatment Projects (WWT)

  Surat


Sheel Biotech Limited

  Business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants

  New Delhi


Munish Forge Limited

  Manufacturing premium forged and cast components

  Ludhiana


Peer Companies Of This Sector

FAQs

Aptus Pharma operates in Pharmaceutical and Marketing, And Distribution Of Finished Pharmaceutical Formulations. The Issue is listed on BSE SME in Sep, 2025. Aptus Pharma IPO size was 13.02 Cr. with Issue price of 70.00 .

Aptus Pharma IPO subscription was 22.27 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Aptus Pharma IPO listed at a listing price of 80.80 against the offer price of 70.00.

The current market price of Aptus Pharma is 88.32.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency